These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12815572)

  • 1. Growth hormone resistance in chronic heart failure and its therapeutic implications.
    Cicoira M; Kalra PR; Anker SD
    J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does growth hormone play a role in chronic heart failure?
    Volterrani M; Giustina A; Lorusso R; Giordano A
    Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans.
    Böger RH
    J Endocrinol Invest; 1999; 22(5 Suppl):75-81. PubMed ID: 10442575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
    Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
    Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.
    Chaggar PS; Malkin CJ; Shaw SM; Williams SG; Channer KS
    Cardiovasc Ther; 2009; 27(3):187-93. PubMed ID: 19689618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the GH/IGF-I axis for cardiac function and structure.
    Isgaard J; Tivesten A; Friberg P; Bengtsson BA
    Horm Metab Res; 1999; 31(2-3):50-4. PubMed ID: 10226781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH and IGF-I as therapeutic agents for osteoporosis.
    Agnusdei D; Gentilella R
    J Endocrinol Invest; 2005; 28(8 Suppl):32-6. PubMed ID: 16323827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I (IGF-I) measurements in growth hormone (GH) therapy of idiopathic short stature (ISS).
    Park P; Cohen P
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S13-20. PubMed ID: 16039893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human insulin-like growth factor-1 treatment: ready for primetime.
    Bright GM; Mendoza JR; Rosenfeld RG
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):625-38. PubMed ID: 19717008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC; Dunger DB
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes.
    Flyvbjerg A
    Kidney Int Suppl; 1997 Sep; 60():S12-9. PubMed ID: 9285896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels.
    Schmid C; Bianda T; Zwimpfer C; Zapf J; Wiesli P
    Growth Horm IGF Res; 2005 Aug; 15(4):300-3. PubMed ID: 16054413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: a pilot open, randomized, and controlled clinical trial.
    Li N; Zhou L; Zhang B; Dong P; Lin W; Wang H; Xu R; Ding H
    Dig Liver Dis; 2008 Jul; 40(7):554-9. PubMed ID: 18164672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.